Immediate Impact
66 standout
Citing Papers
Age-Related Macular Degeneration
2024 Standout
Theranostic Fluorescent Probes
2024 Standout
Works of James C. Major being referenced
SAVE (Super-dose Anti-VEGF) Trial: 2.0 mg Ranibizumab for Recalcitrant Neovascular Age-Related Macular Degeneration: 1-Year Results
2013
Staphylococcus aureus Endophthalmitis: Antibiotic Susceptibilities, Methicillin Resistance, and Clinical Outcomes
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| James C. Major | 413 | 235 | 40 | 79 | 26 | 508 | |
| Tanapat Ratanapakorn | 267 | 227 | 22 | 43 | 36 | 478 | |
| Eylem Yaman Pınarcı | 382 | 245 | 13 | 53 | 27 | 467 | |
| Douglas R. Fredrick | 192 | 125 | 67 | 70 | 28 | 443 | |
| Vuslat Gürlü | 228 | 138 | 28 | 49 | 34 | 478 | |
| Harald Knorr | 400 | 210 | 37 | 50 | 16 | 509 | |
| M. Gary Wickham | 177 | 192 | 8 | 63 | 23 | 480 | |
| Joan Dziezyc | 331 | 162 | 15 | 97 | 36 | 552 | |
| Nathan L. Scott | 314 | 257 | 10 | 35 | 33 | 524 | |
| Sonia Pandey | 254 | 164 | 14 | 52 | 31 | 417 | |
| Rui Jiang | 347 | 160 | 23 | 55 | 57 | 507 |
All Works
Loading papers...